Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |